細胞培養製品の世界市場：試薬、培地、血清、細胞自動培養装置、バイオリアクター、遠心分離機、フローサイトメーター、インキュベーター等...市場調査レポートについてご紹介

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.4 MARKETS COVERED 18
1.5 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 MARKET SIZE ESTIMATION 21
2.2 MARKET CRACKDOWN AND DATA TRIANGULATION 23
2.3 MARKET SHARE ESTIMATION 23
2.3.1 KEY DATA FROM SECONDARY SOURCES 24
2.3.2 KEY DATA FROM PRIMARY SOURCES 24
2.3.2.1 Key Industry Insights 25
2.3.3 ASSUMPTIONS 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 29
4.1 CELL EXPANSION MARKET SHOWS HIGH-GROWTH POTENTIAL 29
4.2 GLOBAL CELL EXPANSION MARKET, BY APPLICATION 30
4.3 GLOBAL CELL EXPANSION MARKET, BY REGION 31
4.4 GLOBAL CELL EXPANSION MARKET, BY PRODUCT 32
4.5 CELL EXPANSION MARKET FOR HUMAN CELLS 33
4.6 LIFE-CYCLE ANALYSIS, BY REGION 34

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.2.1 CELL EXPANSION MARKET, BY PRODUCT 36
5.2.2 CELL EXPANSION MARKET, BY CELL TYPE 37
5.2.3 CELL EXPANSION MARKET, BY APPLICATION 37
5.2.4 CELL EXPANSION MARKET, BY END USER 38
5.2.5 CELL EXPANSION MARKET, BY GEOGRAPHY 39
5.3 MARKET DYNAMICS 39
5.3.1 DRIVERS 40
5.3.1.1 Increasing incidence of chronic diseases 40
5.3.1.2 Rising government investments in cell-based research 41
5.3.1.3 Increasing number of awareness programs, conferences, and symposia 41
5.3.1.4 Increasing demand for biologics 42
5.3.1.5 Technological advancements 42
5.3.1.6 Rising investments by companies for research and development of cell-based therapies 42
5.3.1.7 Increasing number of regulatory approvals for cell therapies 43
5.3.1.8 Increasing number of GMP-certified cell therapy production facilities 43
5.3.2 RESTRAINTS 44
5.3.2.1 High cost of research in cell biology 44
5.3.2.2 Ethical concerns regarding research on cell biology 44
5.3.2.3 Stringent legislations related to import of cell-based products 44
5.3.3 OPPORTUNITIES 45
5.3.3.1 3D cell expansion technology: A new opportunity 45
5.3.3.2 High growth prospects in emerging countries 45
5.3.4 CHALLENGES 46
5.3.4.1 Survival of small players and new entrants 46

6 INDUSTRY INSIGHTS 47
6.1 PORTER’S FIVE FORCES ANALYSIS 47
6.1.1 THREAT FROM NEW ENTRANTS 48
6.1.2 BARGAINING POWER OF SUPPLIERS 48
6.1.3 BARGAINING POWER OF BUYERS 48
6.1.4 INTENSITY OF COMPETITIVE RIVALRY 48
6.1.5 THREAT OF SUBSTITUTES 48
6.2 PEST ANALYSIS 48
6.2.1 POLITICAL FACTORS 48
6.2.2 ECONOMIC FACTORS 49
6.2.3 SOCIAL FACTORS 49
6.2.4 TECHNOLOGICAL FACTORS 49
6.3 STRATEGIC BENCHMARKING 49

7 CELL EXPANSION MARKET, BY PRODUCT 51
7.2 INTRODUCTION 52
7.3 CONSUMABLES 53
7.3.1 REAGENTS, MEDIA, & SERA 54
7.3.2 DISPOSABLES 55
7.3.2.1 Tissue culture flasks 57
7.3.2.2 Bioreactor accessories 57
7.3.2.3 Other disposables 58
7.4 INSTRUMENTS 59
7.4.1 AUTOMATED CELL EXPANSION SYSTEMS 61
7.4.2 BIOREACTORS 61
7.4.2.1 Microcarrier Bioreactors 63
7.4.2.1.1 Microcarrier-based anchorage-dependent bioreactors 64
7.4.2.1.2 Suspension-based anchorage independent bioreactors 65
7.4.2.2 Perfusion/hollow fiber bioreactors 66
7.4.3 CELL EXPANSION SUPPORTING EQUIPMENT 66
7.4.3.1 Centrifuges 69
7.4.3.2 Flow cytometers 69
7.4.3.3 Filtration systems 70
7.4.3.4 Microscopes 71
7.4.3.5 Incubators 73
7.4.3.6 Laminar air flow cabinets 73
7.4.3.7 Other equipment 74

8 CELL EXPANSION MARKET, BY CELL TYPE 76
8.1 INTRODUCTION 77
8.2 HUMAN CELLS 78
8.2.1 STEM CELLS 80
8.2.2 DIFFERENTIATED CELLS 80
8.3 ANIMAL CELLS 81

9 CELL EXPANSION MARKET, BY APPLICATION 83
9.1 INTRODUCTION 84
9.2 CANCER AND STEM CELL RESEARCH 85
9.3 REGENERATIVE MEDICINE 86
9.4 BIOTECHNOLOGY AND BIOPHARMACEUTICAL APPLICATIONS 87
9.5 CLINICAL DIAGNOSTICS 88

10 CELL EXPANSION MARKET, BY END USER 90
10.1 INTRODUCTION 91
10.2 RESEARCH INSTITUTES 92
10.3 HOSPITALS AND DIAGNOSTIC LABORATORIES 93
10.4 CELL BANKS 94
10.5 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES 95

11 CELL EXPANSION MARKET, BY GEOGRAPHY 96
11.1 INTRODUCTION 97
11.2 NORTH AMERICA 100
11.2.1 U.S. 105
11.2.2 CANADA 108
11.3 EUROPE 110
11.3.1 GERMANY 116
11.3.2 FRANCE 118
11.3.3 U.K. 120
11.3.4 ITALY 122
11.3.5 SPAIN 123
11.3.6 REST OF EUROPE 125
11.4 ASIA 127
11.4.1 JAPAN 132
11.4.2 INDIA 134
11.4.3 CHINA 137
11.4.4 REST OF ASIA 139
11.5 REST OF THE WORLD 140

12 COMPETITIVE LANDSCAPE 146
12.1 OVERVIEW 146
12.2 MARKET SHARE ANALYSIS 147
12.3 COMPETITIVE SITUATION AND TRENDS 148
12.3.1 NEW PRODUCT LAUNCHES 149
12.3.2 ACQUISITIONS 149
12.3.3 EXPANSIONS 150
12.3.4 AGREEMENTS & COLLABORATIONS 151
12.3.5 OTHER DEVELOPMENTS 152

13 COMPANY PROFILES 153
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 INTRODUCTION 153
13.2 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION) 154
13.3 BECTON DICKINSON AND COMPANY 157
13.4 CORNING, INC. 160
13.5 GE HEALTHCARE (A FULLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 163
13.6 MERCK MILLIPORE (A SEGMENT OF MERCK KGAA) 166
13.7 MILTENYI BIOTEC 168
13.8 SIGMA-ALDRICH CORPORATION 170
13.9 STEMCELL TECHNOLOGIES 172
13.10 TERUMO BCT (A SUBSIDIARY OF TERUMO CORPORATION) 174
13.11 THERMO FISHER SCIENTIFIC, INC. 176
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
 
14 APPENDIX 179
14.1 INSIGHTS FROM INDUSTRY EXPERTS 179
14.2 DISCUSSION GUIDE 180
14.3 AVAILABLE CUSTOMIZATIONS 183
14.4 RELATED REPORTS 184
14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 185